Mentari Therapeutics, Inc. (MTRI)
NASDAQ: MTRI · Real-Time Price · USD
18.60
+0.25 (1.36%)
At close: Nov 13, 2026, 4:00 PM EST
18.68
+0.08 (0.43%)
After-hours: Nov 13, 2026, 7:30 PM EST
Mentari Therapeutics Market Cap
Mentari Therapeutics has a market cap or net worth of $11.18 billion as of November 13, 2026. Its market cap has increased by 151,648.99% in one year.
Market Cap
11.18B
Enterprise Value
n/a
1-Year Change
151,648.99%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 30, 2013, Mentari Therapeutics's market cap has increased from $904.37K to $11.18B, an increase of 1,236,373.08%. That is a compound annual growth rate of 107.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 11.18B | 151,648.99% |
| Dec 31, 2025 | 7.37M | - |
| Dec 31, 2024 | 7.37M | - |
| Dec 29, 2023 | 7.37M | - |
| Dec 30, 2022 | 7.37M | - |
| Dec 31, 2021 | 7.37M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Summit Therapeutics | 12.06B |
| Halozyme Therapeutics | 11.48B |
| Bio-Techne | 11.44B |
| BioMarin Pharmaceutical | 10.98B |
| Kymera Therapeutics | 10.86B |
| Vaxcyte | 10.24B |
| Madrigal Pharmaceuticals | 9.88B |
| Spyre Therapeutics | 9.77B |